Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC
Public ClinicalTrials.gov record NCT00828841. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center Randomized Phase 2b Study of Cetuximab (Erbitux) in Combination With Platinum-Based Chemotherapy as First Line Treatment of Patients With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is testing the investigational drug, cetuximab, in combination with different chemotherapy drugs for lung cancer. The aim of the study is to determine which of the drug combinations looks most promising and should be tested further. The study will also look at what side effects may occur.
Study identification
- NCT ID
- NCT00828841
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 601 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2008
- Primary completion
- Jun 30, 2012
- Completion
- Jul 31, 2012
- Last update posted
- Nov 5, 2013
2008 – 2012
United States locations
- U.S. sites
- 84
- U.S. states
- 32
- U.S. cities
- 84
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Anniston | Alabama | — | — |
| Not listed | Jonesboro | Arkansas | — | — |
| Not listed | Anaheim | California | — | — |
| Not listed | Azusa | California | — | — |
| Not listed | Burbank | California | — | — |
| Not listed | Campbell | California | — | — |
| Not listed | Greenbrae | California | — | — |
| Not listed | Hawthorne | California | — | — |
| Not listed | Mission Hills | California | — | — |
| Not listed | Orange | California | — | — |
| Not listed | Oxnard | California | — | — |
| Not listed | St. Helena | California | — | — |
| Not listed | Fort Collins | Colorado | — | — |
| Not listed | Norwich | Connecticut | — | — |
| Not listed | Torrington | Connecticut | — | — |
| Not listed | Trumbull | Connecticut | — | — |
| Not listed | Fort Lauderdale | Florida | — | — |
| Not listed | Lake Worth | Florida | — | — |
| Not listed | Orange City | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Titusville | Florida | — | — |
| Not listed | Weston | Florida | — | — |
| Not listed | Augusta | Georgia | — | — |
| Not listed | Columbus | Georgia | — | — |
| Not listed | Lawrenceville | Georgia | — | — |
| Not listed | Marietta | Georgia | — | — |
| Not listed | Valdosta | Georgia | — | — |
| Not listed | Elmhurst | Illinois | — | — |
| Not listed | Harvey | Illinois | — | — |
| Not listed | Joliet | Illinois | — | — |
| Not listed | Quincy | Illinois | — | — |
| Not listed | Skokie | Illinois | — | — |
| Not listed | South Bend | Indiana | — | — |
| Family Medicine of Vincennes | Vincennes | Indiana | — | — |
| Not listed | Arnes | Iowa | — | — |
| Not listed | Bettendorf | Iowa | — | — |
| Not listed | Mason City | Iowa | — | — |
| Not listed | Waterloo | Iowa | — | — |
| Not listed | Hazard | Kentucky | — | — |
| Not listed | Louisville | Kentucky | — | — |
| Not listed | Lafayette | Louisiana | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Baltimore | Maryland | — | — |
| Not listed | Towson | Maryland | — | — |
| Not listed | Springfield | Massachusetts | — | — |
| Not listed | Worchester | Massachusetts | — | — |
| Not listed | Jefferson City | Missouri | — | — |
| Not listed | Saint Joseph | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Billings | Montana | — | — |
| Not listed | Grand Island | Nebraska | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Portsmouth | New Hampshire | — | — |
| Not listed | Bellville | New Jersey | — | — |
| Not listed | Cherry Hill | New Jersey | — | — |
| Not listed | Elizabeth | New Jersey | — | — |
| Not listed | Hackensack | New Jersey | — | — |
| Not listed | East Setauket | New York | — | — |
| Not listed | Fresh Meadows | New York | — | — |
| Not listed | The Bronx | New York | — | — |
| Not listed | Fayetteville | North Carolina | — | — |
| Not listed | Gastonia | North Carolina | — | — |
| Not listed | Goldsboro | North Carolina | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Middletown | Ohio | — | — |
| Not listed | Sandusky | Ohio | — | — |
| Not listed | Bend | Oregon | — | — |
| Not listed | Bethlehem | Pennsylvania | — | — |
| Not listed | Reading | Pennsylvania | — | — |
| Not listed | Sumter | South Carolina | — | — |
| Not listed | Sioux Falls | South Dakota | — | — |
| Not listed | Bristol | Tennessee | — | — |
| Not listed | Chattanooga | Tennessee | — | — |
| Not listed | Memphis | Tennessee | — | — |
| Not listed | Beaumont | Texas | — | — |
| Not listed | Corpus Christi | Texas | — | — |
| Not listed | Lubbock | Texas | — | — |
| Not listed | Bennington | Vermont | — | — |
| Not listed | Kirkland | Washington | — | — |
| Not listed | Tacoma | Washington | — | — |
| Not listed | Huntington | West Virginia | — | — |
| Not listed | Wauwatosa | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00828841, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 5, 2013 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00828841 live on ClinicalTrials.gov.